We are live on ! Find out more
SF

Synovus Financial Portfolio holdings

AUM $8.74B
1-Year Est. Return 12.78%
This Fund
S&P 500
This Quarter Est. Return
+11%
1 Year Est. Return
+12.78%
3 Year Est. Return
+68.37%
5 Year Est. Return
+75.37%
10 Year Est. Return
+242.26%
AUM
$7.06B
AUM Growth
-$1.7B
Cap. Flow
-$2.44B
Cap. Flow %
-34.55%
Top 10 Hldgs %
48.23%
Holding
894
New
57
Increased
306
Reduced
408
Closed
73

Sector Composition

Rank Sector Weight
1 Industrials 18.31%
2 Technology 10.33%
3 Consumer Staples 10.31%
4 Financials 8.74%
5 Healthcare 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYG icon
801
Lloyds Banking Group
LYG
$87.2B
$157K ﹤0.01%
65,674
+167
+0.3% +$358
FHN icon
802
First Horizon
FHN
$12.3B
$153K ﹤0.01%
10,796
-1,508
-12% -$18.2K
LNSR icon
803
LENSAR
LNSR
$65.7M
$151K ﹤0.01%
43,060
RYAM icon
804
Rayonier Advanced Materials
RYAM
$591M
$148K ﹤0.01%
+36,500
New +$120K
EFR
805
Eaton Vance Senior Floating-Rate Fund
EFR
$312M
$147K ﹤0.01%
11,587
TEVA icon
806
Teva Pharmaceuticals
TEVA
$36.9B
$141K ﹤0.01%
13,547
-1,387
-9% -$12.9K
NZF icon
807
Nuveen Municipal Credit Income Fund
NZF
$2.42B
$132K ﹤0.01%
11,177
-331
-3% -$3.63K
FAX
808
abrdn Asia-Pacific Income Fund
FAX
$595M
$127K ﹤0.01%
7,792
-60
-0.8% -$934
UEIC icon
809
Universal Electronics
UEIC
$58.1M
$111K ﹤0.01%
11,806
-90
-0.8% -$736
GUT
810
Gabelli Utility Trust
GUT
$573M
$81.7K ﹤0.01%
15,468
GALT icon
811
Galectin Therapeutics
GALT
$223M
$79.7K ﹤0.01%
48,000
KODK icon
812
Kodak
KODK
$812M
$70.8K ﹤0.01%
18,161
-5,772
-24% -$22.2K
PGEN icon
813
Precigen
PGEN
$1.97B
$65.7K ﹤0.01%
49,065
CLSD
814
DELISTED
Clearside Biomedical
CLSD
$62.1K ﹤0.01%
3,538
-333
-9% -$4.75K
NMR icon
815
Nomura Holdings
NMR
$28.1B
$61.4K ﹤0.01%
13,612
CDE icon
816
Coeur Mining
CDE
$15.4B
$54.8K ﹤0.01%
16,800
MPT
817
Medical Properties Trust
MPT
$2.89B
$49.1K ﹤0.01%
+10,000
New +$49K
PRCH icon
818
Porch Group
PRCH
$1.38B
$49K ﹤0.01%
15,917
XBIT icon
819
XBiotech
XBIT
$69.2M
$47.2K ﹤0.01%
11,796
NKLA
820
DELISTED
Nikola Corporation Common Stock
NKLA
$26.2K ﹤0.01%
1,000
-33
-3% -$1.02K
TCRT icon
821
Alaunos Therapeutics
TCRT
$4.64M
$2.9K ﹤0.01%
273
ACHC icon
822
Acadia Healthcare
ACHC
$3.01B
-3,102
Closed -$218K
ACWX icon
823
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
-207,782
Closed -$9.77M
AKAM icon
824
Akamai
AKAM
$16.3B
-3,577
Closed -$381K
AMRX icon
825
Amneal Pharmaceuticals
AMRX
$5.99B
-10,222
Closed -$43.1K

Similar funds

Synovus Financial's Q4 2023 Portfolio in Review

As of Q4 2023, Synovus Financial held 894 positions worth $7.06B, down 19% from $8.76B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Synovus Financial withdrew a net $2.44B in Q4 2023, closing 73 positions and reducing 408 holdings. Its most notable exit was iShares MSCI ACWI ex US ETF, an estimated $9.77M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Synovus Financial opened a new position in Occidental Petroleum worth $2.89M.

  • Synovus Financial's largest Q4 2023 buy was Occidental Petroleum: 48,464 shares worth $2.89M.
  • Synovus Financial added most to John Hancock Multifactor Mid Cap ETF in Q4 2023, an estimated $8.32M increase.
  • Synovus Financial's biggest Q4 2023 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $335M.
  • Synovus Financial fully exited iShares MSCI ACWI ex US ETF in Q4 2023, selling an estimated $9.77M.
  • Synovus Financial's ten largest holdings make up 48% of its $7.06B portfolio in Q4 2023.
  • Synovus Financial opened 57 new positions and closed 73 in Q4 2023.
  • Synovus Financial's portfolio value fell 19% quarter-over-quarter to $7.06B.

Based on Synovus Financial's 13F filing for Q4 2023, filed 14 Feb 2024.